IBSA Institut Biochimique SA is a privately owned pharmaceutical company founded in Lugano in 1945.
It started to develop its specific identity in 1985, when the current management took over, redefining its strategy and focusing on developing technologies that improve the quality of existing therapeutic solutions.
Today, it is present on 5 continents and over 90 countries. The Group now counts on 18 subsidiaries in Europe, China and USA, and boasts a product portfolio covering 10 therapeutic areas.
The company employs over 2,200 people, distributed among its headquarters, subsidiaries and manufacturing sites.
IBSA is one of the four largest operators worldwide in the area of Reproductive Medicine and one of the world's leaders in hyaluronic acid-based products.
Therapeutic areas:
馃敼 Reproductive Medicine
馃敼 Endocrinology
馃敼 Pain and Inflammation
馃敼 Osteoarticular
馃敼 Aesthetic Medicine
馃敼 Dermatology
馃敼 Uro-gynaecology
馃敼 Cardiometabolic
馃敼 Respiratory
馃敼 Consumer Health